917 results on '"Sobrinho-Simões, Manuel"'
Search Results
2. The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms
3. Mature cystic teratoma of the ovary with malignant transformation of tall cell subtype of papillary thyroid carcinoma
4. Clinical Advantages and Limitations of Tumors Displaying Minimal and Extensive Vascular Invasion
5. Overview of the 2022 WHO Classification of Thyroid Neoplasms
6. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression
7. S616-p-DRP1 associates with locally invasive behavior of follicular cell-derived thyroid carcinoma
8. Rare Familial Tumours
9. Therapeutic Options
10. Other Rare Tumours and Tumour-Like Lesions
11. Small Cell Tumours
12. Rare Papillary Thyroid Carcinomas
13. Introduction
14. Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
15. Tumores de la glándula tiroides. Propuesta para el manejo y estudio de las muestras de pacientes con neoplasias tiroideas
16. Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations—is the term “thyroblastoma” more appropriate?
17. Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers
18. Genomic profiling of primary and metastatic thyroid cancers
19. Is Low-Dose Radiation Exposure a Risk Factor for Atherosclerotic Disease?
20. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
21. PB1816: RUNX1 GERMLINE VARIANT AND CLONAL EVOLUTION TO ACUTE MYELOID LEUKEMIA – A FPDMM FAMILY STUDY
22. P421: TARGETED DISRUPTION OF HUMAN FLT3 ERADICATES LEUKEMIC STEM CELLS WITHOUT HARMING HEALTHY HEMATOPOIETIC STEM CELLS
23. Significance of Furin Expression in Thyroid Neoplastic Transformation
24. Thyroid and Parathyroid Glands
25. Accounting for tissue heterogeneity in infrared spectroscopic imaging for accurate diagnosis of thyroid carcinoma subtypes
26. Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma.
27. Genomic profiling of primary and metastatic thyroid cancers.
28. pmTOR is a marker of aggressiveness in papillary thyroid carcinomas
29. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma
30. Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer
31. Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas
32. Non-invasive follicular thyroid neoplasm with papillary-like nuclear feature: clinical, pathological, and molecular update 5 years after the nomenclature revision
33. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
34. Rare Follicular Tumours
35. Small Cell Tumours
36. Other Rare Tumours and Tumour-Like Lesions
37. Therapeutic Options
38. Introduction
39. Rare Papillary Thyroid Carcinomas
40. Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
41. Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series
42. Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva : a study from Mozambique
43. 2022 European Thyroid Association Guidelines for the Management of Pediatric Thyroid Nodules and Differentiated Thyroid Carcinoma
44. STAT3 negatively regulates thyroid tumorigenesis
45. An Extraordinary Case of Mesenchymal Chondrosarcoma Metastasis in the Thyroid
46. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors
47. Testemunho “Novas formas de pensar, actuar e partilhar ciência”
48. RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
49. Follicular thyroid carcinoma
50. Poorly differentiated thyroid carcinoma: an evolving entity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.